AGN-151597 (RST-001)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AGN-151597 (RST-001), covering 2021-06-23 to 2021-06-23. Get the full timeline:
Most recent: Clinical Trial Update: AGN-151597 (Formerly RST-001) Phase I/II Trial for Advanced Retinitis Pigmentosa [Phase 1, Phase 2]